Clinical Trials

Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment-naïve or Pre-treated Advanced Dedifferentiated Liposarcoma

Link :
Population : DDLPS any line
Description : MDM2i
PI : A. Razak
Centers Opened : TBD
Phase : Drug access trial
IIST/Pharma : Pharma